Biobot Analytics
PrivateLast Round
VC Round
Jun 6, 2025
Total Funding Raised
$27.5M
Momentum Score
25 /100
Company Overview
Biobot Analytics is a biotechnology and data analytics company that specializes in wastewater-based epidemiology. Founded at MIT in 2017, the company transforms wastewater infrastructure into public health observatories by analyzing sewage samples for pathogens, illicit drugs, and other biomarkers. This data provides public health officials and government bodies with actionable insights to track community health trends, detect disease outbreaks like COVID-19, and understand substance use, such as the opioid epidemic. Biobot was the first company to commercialize wastewater epidemiology and was selected by the U.S. Centers for Disease Control and Prevention (CDC) to help launch its National Wastewater Surveillance System (NWSS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Environmental Monitoring
Business Model
B2G
Customer Profile
Government Contracts, Data as a Service, Services & Consulting, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biobot Analytics Comps
Public and private peers based on sector, stage, and business model.
Biobot Analytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 6, 2025 | ||||
| Grant | Sep 21, 2023 | ||||
| Series A | Oct 22, 2021 | ||||
| Seed | Apr 21, 2020 | ||||
| Seed | May 8, 2018 |
Biobot Analytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed |
| The Engine | Series A, Seed |
| Hyperplane | VC Round |
| Atreides Management | VC Round |
| Plum Alley Investments | Series A |
| Pathbreaker Ventures | Seed |
| Engine Ventures | Seed |
Biobot Analytics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biobot Analytics's valuation, stock price, and market status.
